How this fits in
Inappropriate polypharmacy in older patients imposes a significant burden and may lead to adverse drug events, poor adherence, and geriatric syndromes. Consequently, there has been an increased emphasis on deprescribing and interventions to improve the appropriate use of polypharmacy. Patients' strong beliefs in medicines are often reported as important barriers to deprescribing by GPs. However, beliefs about medication in patients with polypharmacy have scarcely been investigated. Using qualitative and quantitative data this study explored patients' beliefs about and attitudes towards medication, within a population of community dwelling older patients with polypharmacy. Study participants reported strong beliefs in medications with co-existing positive and negative attitudes.
Patient-doctor trust may have influenced beliefs and attitudes towards medicines, highlighting the importance of strong patient-doctor relationships in the context of deprescribing.
INTRODUCTION
Polypharmacy (prescribing of many drugs (appropriately) or too many drugs (inappropriately)) is common in older people. (1, 2) The prevalence of polypharmacy (≥ 5 medications) increased from 17 .8% in 1997 to 60.4% in 2012 in persons aged ≥ 65 in Ireland, and doubled to 20.8% between 1995 and 2010 in Scotland. (3, 4) Polypharmacy is associated with adverse drug reactions, poor medication adherence, geriatric syndromes (e.g. urinary incontinence), potentially inappropriate prescribing (medications where their risks outweigh the benefits and when a safer alternative is available) and increased drug expenditure. (5) (6) (7) (8) Consequently, there has been an increased emphasis on deprescribing (process of medication cessation) and interventions to improve the appropriate use of polypharmacy such as medication reviews delivered by clinical pharmacists. (9) Patients' beliefs about treatment are an important influence on prescription medication use.
Patients may influence prescribing decisions on the basis of their expectations or reluctance to take medicines in some cases. Patients' strong beliefs in medicines, expectations, and resistance to change are often cited as important barriers to deprescribing inappropriate medication in older adults by general practitioners (GPs). (10) (11) (12) (13) Patient belief may also influence medication adherence (taking medications as prescribed). Several studies across a wide variety of conditions, have highlighted that people with strong beliefs (as measured by the Beliefs about Medicines Questionnaire (14) ) in the necessity of taking medication to maintain their health are more adherent to medications than those with higher levels of concern about medication. (15, 16) However, the majority of these studies have involved one group of medicines or specific illness groups, while comparatively few studies have examined beliefs about prescribed medication among older patients with polypharmacy in primary care. Considering the important role beliefs may play in medication use, it is important to explore the beliefs of patients with polypharmacy.
The aim of this study was to explore patients' beliefs about and attitudes towards medication, within a population of community dwelling older patients with polypharmacy and explore factors which might influence medication beliefs.
METHODS

Study design
A convergent parallel mixed-method design was adopted.(17) Secondary analysis of available quantitative and qualitative data was conducted separately (described below), and the findings triangulated during the interpretation stage. (17, 18) While quantitative and qualitative data were available on the majority of cases, a mixed methods matrix was not conducted due to missing data. (18) 
Context and study setting
Data were obtained from OPTI-SCRIPT (OPTImizing PreSCRIbing for Older People in Primary Care, a clusTer randomized controlled trial), a pragmatic cluster randomised controlled trial conducted in Ireland. The trial involved 21 GP practices and 196 community dwelling patients aged ≥ 70 years, with pre-existing potentially inappropriate prescribing. (19) The study found that a multifaceted intervention (incorporating academic detailing and GP-led medicines review) was effective in reducing potentially inappropriate prescribing in the intervention group (see Appendix 1 and 2 for more detail). (19) (20) (21) The present study uses cross-sectional data collected at baseline from all participants (May 2012-February 2013), and qualitative data collected during the OPTI-SCRIPT process evaluation (January 2013-August 2013). (22) 
Quantitative data collection and analysis
Medication data
Medication data was collected through review of electronic or paper based patient charts, depending on the practice system. The number of repeat medications per participant (n=196) was controlling illness and concerns about the potential adverse consequences of medications. The necessity-concern differential acts as a cost-benefit analysis, where patients weigh up the concerns (costs) they have about medication against their perception of their necessity (benefit). It is scored -20 to 20 with positive results indicating the patient perceives the benefits outweigh the risks. The Participants were excluded if more than two items on the BMQ were missing. Mean and median scores for the four subscales, and the necessity-concerns differential were calculated. The separate necessity and concern scales were divided at the scale midpoint to create four attitudinal groups, as used in previous studies (23) 
Qualitative data collection and analysis
Qualitative data were collected from one-to-one semi-structured interviews with a purposive sample of participants in the intervention arm of the OPTI-SCRIPT study, to ensure coverage across GP practices, patient gender, and types of medications. All interviews were conducted via telephone by one interviewer (BC) and were audio recorded (on loud speaker). The interview topic guide (Appendix 3) covered aspects of the trial evaluation, and the following broad sections were pertinent to this current study: participants' perceptions of their medications and experiences of GP consultations ( Table 1) .
All interviews were transcribed verbatim by one interviewer (BC) and analysed using a thematic analysis following a six-step process. (24) Two researchers (BC, JAC) independently reviewed the individual transcripts several times to familiarise themselves with the data. Small sections of data were assigned a code that summarised the content. Codes with common features were grouped together in emerging themes, before finally being assigned to overarching themes.(24) Quotations were used as exemplars of key themes. NVivo 10 was used to assist with organizing the data for analysis. All participant data were pseudo-anonymised by assignment of a unique study ID.
RESULTS
Characteristics of participants
Of the 196 participants aged ≥70 in the OPTI-SCRIPT study, 54% were male and the mean age was 76.7 (SD 4.9) years ( Table 2 ). Recruited patients were demographically similar to the general population of those aged 70 and over in Ireland (Appendix 2). A total of 1,862 drugs were recorded with a mean of 9.5 (SD 4.1) per person. Just under half (46%) of participants had excessive polypharmacy (≥10 medicines). Cardiovascular medication was the most frequently prescribed medication category (26.9%), the majority of which were statins, followed by drugs for the alimentary tract & metabolism (18.2%) (Appendix 4).
Most participants (96.3%) believed in the necessity of their medication for maintaining health (i.e. had scores greater than the scale midpoint). Overall, 33.9% reported concerns about potential adverse consequences of taking their medication (i.e. scores greater than the scale midpoint). For the vast majority (94%), the difference between the necessity and concern scores was positive, indicating strong beliefs that the benefits of their medications outweighed the costs (Table 3 ). When participants were categorised by belief group, the majority were found to be either accepting (63.4%) or ambivalent (32.6%) towards their medication ( Figure 1 ).
Most participants believed that medicines were generally beneficial. Only 3% indicated a high belief (i.e. had scores greater than the scale midpoint) that medicines were generally harmful and just over 5% had a high belief (i.e. had scores greater than the scale midpoint) that medicines were generally overused ( Table 3) .
Results from multivariate regression analysis with the four BMQ subscales as the dependent variables, adjusting for demographic factors (Table 4) , demonstrated an increase in the number of repeat medications was significantly associated with an increased score on the necessity subscale (0.23, 95% CI 0.11-0.35, p<0.01).
Participant views on medication
From 14 patients approached, 11 participants were interviewed, 54% of whom were male, with a mean age of 77 years. Interviews ranged from 6.21 to 20.27 minutes ( Table 2 ). Of the 11 participants, six (54.5%) were categorised as accepting, three (27.3%) were ambivalent and two (18.2%) had insufficient data to calculate based on baseline BMQ. From the interview data, three main themes emerged: necessity and concern conflict, knowledge of medications, relationships with health care providers.
Necessity and concern conflict
The majority of participants reported that they accepted medications were necessary to "keep you ticking over" (P655) and "keeping the engine running" (P161). Some participants were however concerned about long-term medication use and potential adverse side-effects, particularly for medications prescribed for prevention of future problems:
"Well maybe, you know you read the leaflets, but I mean you read them and there is everything on it, you know, there could be side-effects, and they just like have them a hundred and one, and you say to yourself, Oh my God. If you get them (medication) for blood pressure, they say they could cause your blood pressure to go up, they could cause heart attacks, you know all this. So you don't know whether you are doing right or wrong having a particular medication, I don't know." (P74) "Well, there is one worry that you do have at the back of your mind, that when, I'm so long on the tablets, you know what I mean, and there might be something happening and I don't know about it because I feel OK, but you don't know." (P125)
Medications prescribed for symptomatic relief of symptoms were viewed as beneficial and more readily accepted, often despite potential side-effects:
"I should say, I didn't take them (medication) one particular morning and didn't take the tablet that night, but by God, I knew all about it the next day. I didn't realise I really relied on those tablets as much as I am. And I'd say if I didn't have those I don't know where I would be." (P1315)
"COPD [Chronic obstructive pulmonary disease] is a nuisance but you just have to take the old inhalers and that. I don't like being on steroids. Recently, as you know I've osteoarthritis, and I was in recently getting injections in my back, for the pain in my back you know, and you know the little thing they put in your arm, to knock you out, that thing, it tore the skin, and just the eh, anaesthetist who was putting, he said 'you must be on steroids', it makes my skin very thin. So that's the bad effect of the steroid, but then, if I need them to breath! Catch 22, isn't it." (P655)
Knowledge of medications
Participants reported variation in the level of knowledge about medications prescribed for them. Some participants were well-informed and comfortable discussing their medications, while others expressed a lower level of understanding:
"… coz we really don't know what we are taking half the time…" (P125)
"So the new tablet now, I don't know the name of it, I do call them by the colours, I do be telling him, the pink one and the green one and the yellow one and the white one…" (P639)
Relationships with health care providers
The majority of participants described positive relationships with their GPs, citing satisfactory aspects of consultation style, including approachability, being listened to, and feeling comfortable:
"I would say, I find that practice very approachable, both Dr X and Dr Y, they're both, you can just speak to them you know, like a friend. Anything I'd have to say I could talk freely with them, you know, there is no kinda, doctor -patient where you are nearly afraid as we were years ago, there's nothing like that, I feel very comfortable with them I suppose is the word." (P655)
"I always find it rewarding because he [GP] is a very knowledgeable man and he is very dedicated." (P1347)
GPs perceived as supportive and engaged, fostered a sense of trust and participants were confident they would make the right treatment decisions, even where reviewing or stopping medications was concerned:
"I trust Dr X, you know with anything she does, you know she only gives me something for a reason, she doesn't just give me it for the sake of it, 'Oh I'll have to get rid of her' or something like that, no. She is very thorough and very conscientious." (P2338)
"Well I mean the doctor said it to me you know, 'O I don't like you taking Difene', I say why, 'because it's very hard on the stomach' you know, and I think it's the kidneys or the liver or something, you know, I accept what they tell me. Well that's what we go to the doctor for isn't it -to be told what's good for your body." (P655)
"I think that is what you would be looking for [review of medication], because nobody wants to take more medications than they need to." (P1345)
Familiarity was a key element, with established relationships and positive past experiences increasing patient confidence:
"I go with him (GP). He's been very good over the years and I'm always led by him. What he says I'll take his word for it as right." (P125)
"I have a very good GP, Dr. Y and he has a few assistants there, and eh, they're all very attentive there I must say, all very very good and he's available at all times, you know, all you do is lift the phone and you get an appointment." (P639)
Some participants did express dissatisfaction about aspects of how medications were prescribed, in terms of information provided, particularly where hospital prescribing was concerned:
"You see people of my age going in to the pharmacist and coming away with a big parcel of stuff, now I wouldn't know, their general, whether they need all them things or not, but I would get the impression that their not keeping, you know, there is probably no need for a lot of the stuff that their taking you know." (P1616) "I'm saying specifically if you go, you go to the hospital rather than your doctor, with something that needs to be done up in the hospital, they treat you, and they say well go on this, you know, do whatever, but they never tell you how long, and you stay on the thing then for, indefinitely like." (P74) Three interviewees spontaneously discussed the role of pharmacists in prescribing, reporting positive interactions, particularly citing helpful innovations they provided such as pill boxes:
"And I now I have got these things, they do it all in the chemist with these packs, it's plastic like a tray, and it's brilliant, and I'm quite happy with that." (P2338)
DISCUSSION
Summary
Using a mixed methods approach, this study among older community dwelling patients with polypharmacy, highlighted that the majority believed in the necessity of their medication. However, this belief was underscored by complex attitudes.
Comparison with existing literature
Older patients with multimorbidity (presence of >1 chronic health condition (25) ) and polypharmacy may be critical of taking numerous medications and conceptualise this as a burden. (26, 27) Similar to a previous Swedish study (28) , the majority of our participants (94%) had strong beliefs in their benefits, however, approximately one-third of participants had strong concerns. For the majority, belief in necessity outweighed any concerns, similar to patterns observed in a frail elderly population. (29) This highlights the complexity of attitudes to prescription medication use, as people possess co-existing accounts of positive and negative attitudes to their medications. (26, 30) Patients may be grateful for the symptom relief provided, but many prescribed medications are used to extend life or for secondary prevention of disease. The qualitative findings highlighted that these medications were harder for patients to accept. Patients are expected to take these medications long-term, often without experiencing any immediate tangible benefit, but being aware of the potential risk of adverse effects, thereby creating uncertainty about the total overall benefit. Despite some patients potentially holding negative views towards medications, evidence suggests most patients adapt to long-term medication use. (26, 31, 32) Our patient population were primarily categorised as accepting (63%). The multivariable regression revealed that as the number of medications increased, so did the score on the BMQ necessity subscale, indicating that as this number increased, beliefs in the necessity became stronger. Patients described their medications as necessary to keep them 'ticking over', indicating a practical acceptance. At the same time however, some participants reported poor knowledge of their medications, a common trait among patients taking multiple drugs, and older people in general tend to have poorer health literacy. (28, 33, 34) This highlights the complex interplay of strong beliefs in the context of limited knowledge. Indeed, a previous study involving frail older patients found no relationship between strong beliefs and medication knowledge.(29) Despite having concerns and reporting poor knowledge, the majority of our participants were accepting and reported a strong belief in the necessity of medications. One explanation for this paradoxical position may lie within the qualitative findings on the doctor-patient relationship -specifically trust.
Interpersonal trust (between patient and clinician) is a key element of the patient-doctor relationship, one particularly valued by older patients. (35) (36) (37) (38) Our results highlight that for patients with polypharmacy, medication taking is often characterised by uncertainty, elements of risk, and information asymmetry between patient and GP (i.e. GPs have more information than patients, creating an imbalance of power). Trust is necessary in such conditions of uncertainty as it reduces complexity, allowing people to make decisions. (39, 40) In this context, trust in the GP may enable patients to negotiate the complexity and uncertainty of polypharmacy. Trust can influence patients' attitudes of medications, with patients likely to develop negative attitudes of medications where their trust in a prescriber is negatively influenced. (30, 32, 41) Along with lack of guidelines and the involvement of multiple prescribers, patients' strong beliefs in medicines are often reported as important barriers to deprescribing by GPs. (10, 11) However, strong beliefs exist against a backdrop of positive and negative attitudes. Our participants had strong beliefs in medicine, yet also expressed willingness to trial stopping medications, similar to other cohorts. (42) This willingness may arise through interpersonal trust as evidence suggests that patients report willingness to trial cessation of medications when recommended a physician they trust. (13) 
Strengths and limitations
Combining qualitative and qualitative data allows a richer analysis. Participants completed questionnaires without a researcher present which may have decreased responder bias. Despite contacting participants to obtain missing data, not all participants answered the BMQ in full. This was taken into account in the analysis, but may have impacted on the results. The qualitative data is limited as it was obtained as part of a larger process evaluation of the OPTI-SCRIPT trial.
Consequently, the sample was limited to trial participants who may not be representative of all older patients, the topic guide was not designed to explore issues of polypharmacy specifically and interviews were shorter on average (14 minutes) than may be expected. While the themes presented here emerged strongly from the data, arguably, a more detailed interview may have produced a more nuanced account. Overall, our results are consistent with limited previous qualitative studies in this area, increasing confidence in the findings.
Implications for research and practice
In light of the increased prevalence of polypharmacy, and associated adverse consequences, it is imperative to develop effective interventions to improve appropriate polypharmacy and patient outcomes. (9, 16) Increasingly, there is a focus on deprescribing, with recent reviews stressing the importance of shared decision making. (43, 44) Patients' strong beliefs in medicines are often reported as important barriers to deprescribing by GPs.(10, 11) However, our findings highlight that strong beliefs often mask a complex interplay of positive and negative attitudes, in the context of limited knowledge and a willingness to stop medications. Patients' beliefs and attitudes about medications may be influenced by the patient-doctor relationship. Patient trust may facilitate a willingness to tolerate polypharmacy in a context of uncertainty, but it may equally influence patients' willingness to deprescribe. Our study provides evidence supporting building strong relationships with patients with complex multimorbidity and polypharmacy to enhance deprescribing. (41) Practical strategies to achieve this include active identification of complex patients, and the adoption of a policy of continuity of care such as assigning these patients a named doctor. (25) Strategies that improve continuity of care may also reduce secondary care costs, particularly for the heaviest users of healthcare. (45) In conclusion, participants reported strong beliefs in medications with co-existing positive and negative attitudes. Furthermore, the patient-doctor relationship may influence beliefs and attitudes towards medicines and deprescribing. 
Could you tell me a little about your medications?
Prompts: what do you take; how many medicines; are your medicines important/necessary; why do you take them; are there any side effects Could you tell me how you feel about taking these medications?
Prompts: How does having to take your medicines impact on you Could you tell me a little about your interactions with your GP?
Prompts: How often do you see them; what do you discuss about your medications; what type of information about your medications do you get 7-20 * GMS General Medical Services card: GMS is a means tested scheme which entitles those who qualify access to public health services, free of charge. Approximately 97% of those aged over 70 years are eligible. Necessity-concern differential Ɨ 6.9 
